Genomic Biomarkers For Pharmaceutical Development: Advancing Personalized Health Care > http://shorl.com/taverotifrely
674da32071
Reed Elsevier trademark is owned and protected by Reed Elsevier Properties SA. Previous Next Article Table of Contents This Article doi: 10.1177/1091581814537035 International Journal of Toxicology July/August 2014 vol. Consequently, managing doses for an individual patient has both clinical and economic benefits, especially when ADRs extract large socioeconomic tolls. Related Content Load related web page information Share CiteULike Connotea Delicious Digg Facebook Google+ LinkedIn Mendeley Reddit StumbleUpon Twitter What's this? . .. Submit a Manuscript Free Sample Copy Email Alerts RSS feed More about this journal About the Journal Editorial Board Manuscript Submission Abstracting/Indexing Subscribe Account Manager Recommend to Library Advertising Reprints Permissions American College of Toxicology Most Most Read Certification in Toxicology: An International Perspective of Risk:Benefit Glyphosate Commercial Formulation Causes Cytotoxicity, Oxidative Effects, and Apoptosis on Human Cells: Differences With its Active Ingredient Eighth Triennial Toxicology Salary Survey Oral Cadmium in Mice Carrying 5 Versus 2 Copies of the Slc39a8 Gene: Comparison of Uptake, Distribution, Metal Content, and Toxicity Combustion By-Products and Their Health Effects--Combustion Engineering and Global Health in the 21st Century: Issues and Challenges View all Most Read articles Most Cited Final Report on the Safety Assessment of t-Butyl Hydroquinone The Dose Determines the Stimulation (and Poison): Development of A Chemical Hormesis Database Structure, Function, Expression, Genomic Organization, and Single Nucleotide Polymorphisms of Human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) Efflux Transporters Bioavailability and Risk Assessment of Orally Ingested Polycyclic Aromatic Hydrocarbons Hormesis Predicts Low-Dose Responses Better Than Threshold Models View all Most Cited articles . Copyright 2015 Elsevier B.V. HOME ALL ISSUES FEEDBACK SUBSCRIBE RSS EMAIL ALERTS HELP Copyright 2016 by American College of Toxicology Print ISSN: 1091-5818 Online ISSN: 1092-874X . 33 no.
Home Life Sciences Genetics Genomics Genomic Biomarkers for Pharmaceutical Development Facebook Twitter Genomic Biomarkers for Pharmaceutical Development, 1st Edition Advancing Personalized Health Care Add to Wish List Editor(s) : Yao & Jallal & Ranade Release Date: 24 Sep 2013 Imprint: Academic Press Print Book ISBN : 9780123973368 eBook ISBN : 9780123977946 Pages: 208 Dimensions: 235 X 191 Features real-world examples and highlights the challenges of how to effectively incorporate pharmacogenomics and other genomic technology into biomarker development and drug life cycle management Print Book + eBook EUR91.14 EUR151.90 Buy both together and save 40% Add to Cart Select format VST (VitalSource Bookshelf) format DRM-free included formats : EPUB, Mobi (for Kindle), PDF, EPUB, Mobi (for Kindle) Print Book Hardcover In Stock Estimated Delivery Time EUR75.95 eBook eBook Overview VST (VitalSource Bookshelf) format DRM-free included formats : EPUB, Mobi (for Kindle), PDF, EPUB, Mobi (for Kindle) EUR75.95 Add to Cart Overview Authors Table of Contents Video Resources Editorial Reviews Key Features Provides case studies in applications of pharmacodynamic and predictive markers in drug development in oncology, autoimmunity, respiratory diseases and infectious diseases Shows how to identify potential new therapeutic targets in different diseases and provides examples of potential new disease indications for life cycle management of drugs Authored by leading international experts from industry and academia Description Genomic Biomarkers for Pharmaceutical Development: Advancing Personalized Health Care provides an in-depth review of the state of translational science across all stages of pharmaceutical development with a special focus on personalized health care. If you are a toxicologist who is not attracted to the book because of its title, you might want to flip your curiosity switch and examine the book, especially chapter 6, ToxicogenomicsA. .. If you are a toxicologist practicing in the pharmaceutical industry, especially if you are immersed in or even in juxtaposition to cancer therapeutics developments, make certain that you have access to the book, if you dont already have your own copy. Sign In to gain access to subscriptions and/or My Tools. Cookies are set by this site. Sign In My Tools Contact Us HELP Search all journals Advanced Search Search History Browse Journals .
The Frontiersmen: A Narrative
Sidney Lanier (v. 5)
Bullying and Sexual Harassment: A practical handbook
Christ the King, Lord of History, Workbook
Reassessing Keith Haring